Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Herbal nano-formulations show potential for effective skin delivery but need more research.

Minoxidil effectively treats female pattern hair loss.

Children with trichotillomania often pull hair from their scalp, and parents may not notice; stress can trigger it, and asking detailed questions helps in diagnosis and treatment.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Tamoxifen caused hair loss in a 52-year-old woman.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The most common skin diseases in Hail, Saudi Arabia, are eczema and acne, with more women affected than men.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Combining light therapy and microneedling shows promise for treating female hair loss.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

More research is needed to understand hair and scalp disorders in people with skin of color.

Scalp hair sweating is a significant predictor of hair cortisol levels.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Women with PCOS have lower self-esteem and body image satisfaction.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.